Menu
  • Join
  • Login
  • Contact
 

Search abstracts


DNP-NMR reveals the interior of lipid nanoparticle/mRNA formulations

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Presentation
  • By: SCHANTZ, Staffan (AstraZeneca R&D, Pharmaceutical Technology&Development, Mölndal, Sweden)
  • Co-author(s): Jasmine Viger-Gravel: EPFL Lausanne, Institute des Sciences et Ingenierie Chimiques, Lausanne, Switzerland
    Anna Schantz: Pharmaceutical Sciences, AstraZeneca R&D, Mölndal, Sweden
    Aaron Rossini: Department of Chemistry, Iowa State university, Iowa, United States
    Arthur Pinon: EPFL Lausanne, Institute des Sciences et Ingenierie Chimiques, Lausanne, Switzerland
    Staffan Schantz: Pharmaceutical Technology&Development, AstraZeneca R&D, Mölndal, Sweden
    Lyndon Emsley: EPFL Lausanne, Institute des Sciences et Ingenierie Chimiques, Lausanne, Switzerland
  • Abstract:

    Backgrounds

    Much interest focus on the development of lipid nanoparticles (LNPs) for the delivery of ribonucleic acids, e.g. small interfering (siRNA) and messenger (mRNA). LNPs are complex entities self-assembled from multiple components of different natures and many questions remain regarding their structure. For example, it is not well

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses